Viridian Therapeutics, Inc.\DE VRDN
NASDAQ VRDN
$20.59 +0.59 (+2.95%)
At close: Sep 30, 2026 · 4:00 PM EDT

Viridian Therapeutics, Inc.\DE (VRDN) Current Assets (2013 - 2026)

Updated

Viridian Therapeutics, Inc.\DE (VRDN) recorded Current Assets of $1.08 billion in Q2 2026, up 86.8% from $578.75 million a year earlier and up 37.8% from the prior quarter.

Analysis

Viridian Therapeutics, Inc.\DE (VRDN) Current Assets (2013 - 2026) Analysis & Trends

At the end of FY2025, Viridian Therapeutics, Inc.\DE reported Current Assets of $894.23 million, up 21.1% from FY2024.

  • Annual Current Assets has increased for six straight years, with a five-year compound annual growth rate of 47.2% (FY2020 to FY2025).
  • Across earlier years, Current Assets came in at $738.46 million in FY2024 (+51.8%), $486.48 million in FY2023 (+12.8%), $431.17 million in FY2022 (+115.4%) and $200.16 million in FY2021 (+54.4%).
  • The Q2 2026 figure is the highest quarterly Current Assets in data going back to Q4 2013.
  • On a year-over-year basis, Current Assets has increased for three consecutive quarters, with growth averaging 36.9% over the last eight quarters.
  • Peak year-over-year performance for Current Assets in the last five years was growth of 581.7% in Q3 2021, against a decline of 26.0% in Q3 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $784.74 million (Q1 2026), $894.23 million (Q4 2025) and $571.91 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 59.77 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 33.67 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 27.35 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 27.97 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 34.96 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 13.95 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 41.36 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 12.54 Bn
10 Viridian Therapeutics, Inc.\DE 2.33 Bn 2.33 Bn - 1.08 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.08 Bn
Mar 31, 2026 784.74 Mn
Dec 31, 2025 894.23 Mn
Sep 30, 2025 571.91 Mn
Jun 30, 2025 578.75 Mn
Mar 31, 2025 657.24 Mn
Dec 31, 2024 738.46 Mn
Sep 30, 2024 767.36 Mn
Jun 30, 2024 581.66 Mn
Mar 31, 2024 626.82 Mn
Dec 31, 2023 486.48 Mn
Sep 30, 2023 323.84 Mn
Jun 30, 2023 346.33 Mn
Mar 31, 2023 382.60 Mn
Dec 31, 2022 431.17 Mn
Sep 30, 2022 437.36 Mn
Jun 30, 2022 166.15 Mn
Mar 31, 2022 179.39 Mn
Dec 31, 2021 200.16 Mn
Sep 30, 2021 217.94 Mn
API Access

Viridian Therapeutics, Inc.\DE Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=VRDN&period=max&api_key=YOUR_API_KEY